4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001415889-25-009075
PRINCIPAL ACCOUNTING OFFICER sold 1,095 shares at $17.05 ($18,670)
- PRINCIPAL ACCOUNTING OFFICER acquired 2,142 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kihara James PRINCIPAL ACCOUNTING OFFICER | 2025-03-25 | Option exercise | +2,142 | 22,370 | D | ||
| Kihara James PRINCIPAL ACCOUNTING OFFICER | 2025-03-26 | Sale | −1,095 | $17.05 | $18,670 | 21,275 | D |
| Derivatives | |||||||
| Kihara James PRINCIPAL ACCOUNTING OFFICER | 2025-03-24 | Grant or award · Stock Option (Right to Buy) | +22,152 | 22,152 | D | ||
| Kihara James PRINCIPAL ACCOUNTING OFFICER | 2025-03-24 | Grant or award · Restricted Stock Units | +6,510 | 6,510 | D | ||
| Kihara James PRINCIPAL ACCOUNTING OFFICER | 2025-03-25 | Option exercise · Restricted Stock Units | −2,142 | 6,426 | D | ||
| Open-market sales · 1,095 sh · avg $17.05 · $18,670 | |||||||
Loading xslF345X05/form4-03272025_120357.xml…